The Rise of GLP-1 Medications – Magnet
US$ 26.38
glp-1 agonists drugs list of approved and pending medications glp 1 and glp 2
Description
The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%
Recent studies have highlighted the effectiveness ofweight loss medications, particularly GLP-1 agonists like Semaglutide (found in Wegovy and Ozempic) and Tirzepatide (found []
Background: The evidence on berberine stimulating the secretion of GLP-1 in intestinal L cell has been studied
The list of conditions for which GLP-1 drugs provides benefit independent of weight loss keeps growing
A new era for weight loss
